Expanded CD4(+)CD45RO(+) phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease

被引:54
作者
Roman, LI
Manzano, L
DelaHera, A
Abreu, L
Rossi, I
AlvarezMon, M
机构
[1] UNIV ALCALA DE HENARES, PRINCIPE ASTURIAS HOSP, DEPT MED, MADRID, SPAIN
[2] CSIC, CTR INVEST BIOL, MADRID, SPAIN
[3] UNIV AUTONOMA MADRID, DEPT GASTROENTEROL, PUERTA HIERRO HOSP, MADRID, SPAIN
关键词
D O I
10.1053/gast.1996.v110.pm8612987
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: An abnormal immune response may play a pathogenic role in Crohn's disease, The aim of this study was to determine the role of regulatory T cells in Crohn's disease. Methods: T-cell phenotype and function were studied in blood lymphocytes from patients with Crohn's disease and a control group consisting of healthy donors and patients with ulcerative colitis, Results: Flow cytometric studies showed a significant increase in the percentage of CD3(+)DR(+) and CD4(+)CD45RO(+) T cells in patients with Crohn's disease, T cells from patients with Crohn's disease and ulcerative colitis showed a defective proliferative response after stimulation with surface mitogenic ligands (phytohemagglutinin and anti-CD28 or anti-CD3 antibodies), Soluble interleukin-2 receptor alpha was augmented in the Crohn's disease and ulcerative colitis groups, In the Crohn's disease group, impairment of T-lymphocyte proliferation was normalized by exogenous interleukin 2, although endogenous interleukin-2 production and interleukin-2 receptor a expression were normal, Conclusions: An in vivo expansion of CD4(+) T lymphocytes with memory phenotype and impaired T-cell proliferation that can be restored by pharmacological amounts of interleukin 2 was found in patients with Crohn's disease, There is a severe immunodisturbance in the T-cell compartment of patients with either clinically active or inactive Crohn's disease.
引用
收藏
页码:1008 / 1019
页数:12
相关论文
共 50 条
[41]   INCREASED INVITRO RELEASE OF SOLUBLE INTERLEUKIN-2 RECEPTOR BY COLONIC LAMINA PROPRIA MONONUCLEAR-CELLS IN INFLAMMATORY BOWEL-DISEASE [J].
SCHREIBER, S ;
RAEDLER, A ;
CONN, AR ;
ROMBEAU, JL ;
MACDERMOTT, RP .
GUT, 1992, 33 (02) :236-241
[42]  
SCHREIBER S, 1992, GASTROENTEROL CLIN N, V21, P451
[44]  
SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125
[45]   IMMUNOLOGICAL MECHANISMS IN INTESTINAL-DISEASES [J].
TARGAN, SR ;
KAGNOFF, MF ;
BROGAN, MD ;
SHANAHAN, F .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :853-870
[46]   CORTISONE IN ULCERATIVE COLITIS - FINAL REPORT ON A THERAPEUTIC TRIAL [J].
TRUELOVE, SC ;
WITTS, LJ .
BRITISH MEDICAL JOURNAL, 1955, 2 (OCT29) :1041-1048
[47]   EARLY STEPS OF LYMPHOCYTE-ACTIVATION BYPASSED BY SYNERGY BETWEEN CALCIUM IONOPHORES AND PHORBOL ESTER [J].
TRUNEH, A ;
ALBERT, F ;
GOLSTEIN, P ;
SCHMITTVERHULST, AM .
NATURE, 1985, 313 (6000) :318-320
[48]  
ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.iy.08.040190.002225
[49]  
WALDMANN TA, 1991, J BIOL CHEM, V266, P2681
[50]   CELL-SURFACE MOLECULES AND EARLY EVENTS INVOLVED IN HUMAN LYMPHOCYTE-T ACTIVATION [J].
WEISS, A ;
IMBODEN, JB .
ADVANCES IN IMMUNOLOGY, 1987, 41 :1-38